Salmeterol + fluticasone deemed safe for childhood asthma

September 2, 2016

(HealthDay)—Children using a combination long-acting beta agonist/steroid inhaler do not have any greater risk of harm than children using a steroid inhaler alone, according to a study published in the Sept. 1 issue of the New England Journal of Medicine.

Stanley Szefler, M.D., director of pediatric asthma research for the University of Colorado School of Medicine in Aurora, and colleagues recruited 6,208 children between 4 and 11 years old. They were randomly assigned inhalers containing a combination of salmeterol and fluticasone, or fluticasone alone.

Of all the patients, 27 in the combination drug group had a serious asthma-related event that required hospitalization, compared with 21 in the steroid-only group. There were no deaths, and no emergencies that required endotracheal intubation.

"The next step is for the FDA to assemble all the available studies, make their own interpretation, and determine how that would affect product labeling," Szefler told HealthDay.

Several authors disclosed to , including GlaxoSmithKline, which manufactures Advair (fluticasone/salmeterol) and funded the study.

Explore further: ATS: Indacaterol-glycopyrronium cuts COPD exacerbations

More information: Full Text (subscription or payment may be required)

Related Stories

ATS: Indacaterol-glycopyrronium cuts COPD exacerbations

May 16, 2016
(HealthDay)—For patients with a history of chronic obstructive pulmonary disease (COPD) exacerbations, indacaterol-glycopyrronium is more effective for prevention of exacerbations than salmeterol-fluticasone, according ...

1990s trial gave early danger signs for asthma drugs

November 25, 2012
The troubled history of asthma drugs known as long-acting beta-agonists goes back to the 1990s when a large clinical trial in Great Britain of the GlaxoSmithKline drug Serevent produced disturbing results.

Study shows combination drug therapy for asthma patients is safe

August 31, 2016
A post-marketing safety study mandated by the U.S. Food and Drug Administration has shown that a combination drug therapy for the treatment of asthma is safe and effective.

FDA panel backs Glaxo inhaler for adults, not adolescents

March 19, 2015
Government health advisers say a once-a-day respiratory inhaler from GlaxoSmithKline appears safe and effective for adults with asthma, but not for adolescents.

Nebulizers deliver less than half of prescribed asthma Rx in kids

November 25, 2013
(HealthDay)—The amount of corticosteroids delivered by nebulizers in children with asthma differs from the prescribed dose, the amount varying with drug formulation, according to research published online Nov. 24 in Respirology.

Screening for 'changed gene' could prevent asthma attacks and improve treatment

January 11, 2016
Screening children with asthma for a specific genetic change could help prevent asthma attacks and lead to more effective treatments, according to scientists at the University of Aberdeen.

Recommended for you

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

July 12, 2017
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune ...

A perturbed skin microbiome can be 'contagious' and promote inflammation, study finds

June 29, 2017
Even in healthy individuals, the skin plays host to a menagerie of bacteria, fungi and viruses. Growing scientific evidence suggests that this lively community, collectively known as the skin microbiome, serves an important ...

Inflammatory bowel disease: Scientists zoom in on genetic culprits

June 28, 2017
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. The team from the Wellcome Trust Sanger Institute and their collaborators ...

Trials show unique stem cells a potential asthma treatment

June 28, 2017
A study led by scientists at Monash University has shown that a new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.

Researchers find piece in inflammatory disease puzzle

May 23, 2017
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

Researchers reveal potential target for the treatment of skin inflammation in eczema and psoriasis

May 22, 2017
Superficially, psoriasis and atopic dermatitis may appear similar but their commonalities are only skin deep. Atopic dermatitis, also known as eczema, is primarily driven by an allergic reaction, while psoriasis is considered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.